BioLASCO Taiwan Co., Ltd. (TPEX:6662)

BioLASCO Taiwan Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.14	106.82	142.97	168.5	201.17	201.47
Short-Term Investments	55.7	55.7	58.7	58.7	43.3	43.3
Cash & Short-Term Investments	151.84	162.52	201.67	227.2	244.47	244.77
Cash Growth	-7.84%	-19.41%	-11.24%	-7.06%	-0.12%	-15.64%
Accounts Receivable	45.87	44.48	49.41	31.35	30.51	49.38
Receivables	45.87	44.48	49.41	31.35	30.51	49.38
Inventory	27.76	37.84	34.3	26.22	19.34	21.07
Prepaid Expenses	1.16	1.03	1.04	0.8	0.71	0.67
Other Current Assets	2.85	3.41	3.43	1.76	2.06	0.12
Total Current Assets	229.48	249.28	289.84	287.34	297.08	316
Property, Plant & Equipment	240.24	237.64	190.71	197.13	199.35	203.01
Long-Term Investments	123.3	116.94	83.29	72.76	64.51	52.27
Other Intangible Assets	0.3	0.33	0.34	0.46	0.1	0.02
Long-Term Deferred Tax Assets	1.59	1.99	2.65	4.29	5.25	5.77
Other Long-Term Assets	6.81	6.48	6.3	7.71	7.98	12.32
Total Assets	601.71	612.67	573.14	569.69	574.26	589.38
Accounts Payable	6.04	19.61	5.49	8.44	5.67	4.42
Accrued Expenses	8.07	17.97	17.74	16.55	15.91	19.4
Current Portion of Long-Term Debt	12.64	11.27	5.33	5.33	5.33	5.33
Current Portion of Leases	1.68	1.14	1.44	2.41	0.83	1.67
Current Income Taxes Payable	6.02	5.1	10.6	9.63	10.69	8.43
Current Unearned Revenue	4.55	1.65	7.77	3.96	2.66	3.37
Other Current Liabilities	48.49	11.36	11.69	10.1	9.06	9.85
Total Current Liabilities	87.49	68.1	60.07	56.42	50.14	52.46
Long-Term Debt	91.6	94.52	51.28	56.61	61.94	66.92
Long-Term Leases	1.74	0.08	0.16	1.6	1.07	0.21
Long-Term Deferred Tax Liabilities	0.57	0.59	0.48	0.43	0.32	0.27
Total Liabilities	181.4	163.29	111.98	115.05	113.91	121.6
Common Stock	256.12	256.12	256.12	256.12	256.12	256.12
Additional Paid-In Capital	84.11	95.64	95.64	102.04	102.04	102.04
Retained Earnings	103.22	125.7	123.6	105.81	104.01	109.21
Comprehensive Income & Other	-23.14	-28.09	-14.21	-9.34	-1.82	0.41
Total Common Equity	420.31	449.38	461.16	454.64	460.36	467.79
Shareholders' Equity	420.31	449.38	461.16	454.64	460.36	467.79
Total Liabilities & Equity	601.71	612.67	573.14	569.69	574.26	589.38
Total Debt	107.67	107.01	58.21	65.95	69.18	74.13
Net Cash (Debt)	44.17	55.51	143.46	161.26	175.29	170.64
Net Cash Growth	-58.54%	-61.31%	-11.04%	-8.01%	2.73%	-38.31%
Net Cash Per Share	1.72	2.16	5.59	6.28	6.83	6.65
Filing Date Shares Outstanding	25.61	25.61	25.61	25.61	25.61	25.61
Total Common Shares Outstanding	25.61	25.61	25.61	25.61	25.61	25.61
Working Capital	141.99	181.19	229.78	230.92	246.94	263.53
Book Value Per Share	16.41	17.55	18.01	17.75	17.97	18.26
Tangible Book Value	420.02	449.05	460.82	454.18	460.26	467.76
Tangible Book Value Per Share	16.40	17.53	17.99	17.73	17.97	18.26
Land	-	149.68	117.39	117.39	117.39	117.39
Buildings	-	114.09	102.5	102.5	102.5	101.12
Machinery	-	28.35	25.4	24.22	23.52	22.48
Construction In Progress	-	5.6	-	-	-	-
Leasehold Improvements	-	-	0.38	-	5.32	5.24

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.